155 related articles for article (PubMed ID: 37025490)
1. Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis.
Bi Y; Shi K; Chen J; Wang X
Front Pharmacol; 2023; 14():1159222. PubMed ID: 37025490
[No Abstract] [Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis.
Zhao J; Ai J; Mo C; Shi W; Meng L
Complement Ther Med; 2022 Aug; 67():102831. PubMed ID: 35398481
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review.
Li X; Liao M; Pan Q; Xie Q; Yang H; Peng Y; Li Q; Qu J; Chai J
Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1116-1122. PubMed ID: 32649329
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
[TBL] [Abstract][Full Text] [Related]
6. Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis.
Jiang Y; Li H; Song D; Ye P; Xu N; Chen Y; Zhang W; Hu Q; Ma X; Wen J; Li Y; Zhao Y
Front Pharmacol; 2021; 12():774884. PubMed ID: 34916949
[No Abstract] [Full Text] [Related]
7. Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: A network meta-analysis.
Liu J; Zhang X; Xu G
Front Pharmacol; 2022; 13():939488. PubMed ID: 36071841
[No Abstract] [Full Text] [Related]
8. [Ursodeoxycholic acid combined with bezafibrate in the treatment of refractory primary biliary cholangitis: a meta-analysis].
Feng BL; Yu HH; Shen W
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):304-311. PubMed ID: 31082343
[No Abstract] [Full Text] [Related]
9. Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis.
Wang ZL; Song KM; Jin R; Xie YD; Wang YQ; Liu ZC; Feng B
Medicine (Baltimore); 2022 Mar; 101(9):e28987. PubMed ID: 35244071
[TBL] [Abstract][Full Text] [Related]
10. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
Li XQ; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
[TBL] [Abstract][Full Text] [Related]
11. Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis.
Mei J; Xu H; Xu FQ; Ju JQ
Chin J Integr Med; 2019 Oct; 25(10):770-777. PubMed ID: 31127505
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Saffioti F; Gurusamy KS; Eusebi LH; Tsochatzis E; Davidson BR; Thorburn D
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011648. PubMed ID: 28350426
[TBL] [Abstract][Full Text] [Related]
13. A Network Meta-Analysis of the Clinical Efficacy and Safety of Commonly Used Chinese Patent Medicines in the Auxiliary Treatment of Poststroke Depression.
Yu Y; Zhang G; Han T; Liu H; Huang H
Evid Based Complement Alternat Med; 2022; 2022():7265769. PubMed ID: 35035507
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Chinese medicines for vitreous hemorrhage: A protocol for systematic review and meta-analysis.
Han M; Liu Z; Nong L; Zi Y; Meng H; Deng Y; Wang ZJ; Jin M
Medicine (Baltimore); 2020 May; 99(19):e20086. PubMed ID: 32384479
[TBL] [Abstract][Full Text] [Related]
15. [Effect of ursodeoxycholic acid with traditional Chinese medicine on biochemical response in patients with primary biliary cholangitis: a real-world cohort study].
Chen JL; Yang X; Zhang Q; Sun L; Liu Y; Zhu BB; Wang XB
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):909-915. PubMed ID: 30669783
[No Abstract] [Full Text] [Related]
16. Ursodeoxycholic acid for primary biliary cirrhosis.
Gong Y; Huang ZB; Christensen E; Gluud C
Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
[TBL] [Abstract][Full Text] [Related]
17. [Network Meta-analysis of Chinese patent medicines of Ziziphi Spinosae Semen in treatment of primary insomnia].
Yao WQ; Zhao YH; Zheng YW; Zhang Q; Han X
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4541-4554. PubMed ID: 34581060
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Chinese Patent Medicine for the Prevention and Treatment of Radiotherapy and Chemotherapy-Induced Oral Mucositis: A Systematic Review and Meta-Analysis.
Xie Y; Fang X; Hua H; Zhou P
Front Pharmacol; 2022; 13():812085. PubMed ID: 35418855
[No Abstract] [Full Text] [Related]
19. Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators.
Qian JD; Yao TT; Wang Y; Wang GQ
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):874-884. PubMed ID: 32305248
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
